[Clinical investigation of intermediate- and high-purity antihaemophilic factor (factor VIII) concentrates].
D000328:Adult; D000535:Aluminum / Q000097:blood; D000818:Animals; D001780:Blood Coagulation Tests; D004285:Dogs; D005167:Factor VII / Q000627:therapeutic use*; D005169:Factor VIII / Q000008:administration & dosage; D006018:Glycols / Q000009:adverse effects; D006168:Guinea Pigs; D006467:Hemophilia A / Q000188:drug therapy; D006470:Hemorrhage / Q000517:prevention & control; D006487:Hemostasis; D006505:Hepatitis / Q000150:complications; D006801:Humans; D007223:Infant; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010973:Platelet Adhesiveness; D011817:Rabbits; D051381:Rats; D013514:Surgical Procedures, Operative; D014081:Tooth Extraction; D014842:von Willebrand Diseases / Q000188:drug therapy
D006018:Glycols; D005167:Factor VII; D005169:Factor VIII; D000535:Aluminum